McKesson EBITDA 2006-2019 | MCK

McKesson annual and quarterly EBITDA history from 2006 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • McKesson EBITDA for the quarter ending March 31, 2019 was $1.074B, a 8.7% increase year-over-year.
  • McKesson EBITDA for the twelve months ending March 31, 2019 was $3.914B, a 0.41% decline year-over-year.
  • McKesson 2019 annual EBITDA was $3.914B, a 0.41% decline from 2018.
  • McKesson 2018 annual EBITDA was $3.93B, a 52.78% decline from 2017.
  • McKesson 2017 annual EBITDA was $8.322B, a 87.52% increase from 2016.
McKesson Annual EBITDA
(Millions of US $)
2019 $3,914
2018 $3,930
2017 $8,322
2016 $4,438
2015 $4,226
2014 $3,174
2013 $2,928
2012 $2,617
2011 $2,317
2010 $2,482
2009 $1,637
2008 $1,849
2007 $1,559
2006 $1,388
2005 $29
McKesson Quarterly EBITDA
(Millions of US $)
Q4 2019 $1,074
Q3 2018 $982
Q2 2018 $930
Q1 2018 $928
Q4 2018 $988
Q3 2017 $1,068
Q2 2017 $1,014
Q1 2017 $860
Q4 2017 $4,986
Q3 2016 $1,035
Q2 2016 $1,087
Q1 2016 $1,214
Q4 2016 $962
Q3 2015 $1,140
Q2 2015 $1,176
Q1 2015 $1,160
Q4 2015 $1,172
Q3 2014 $1,048
Q2 2014 $1,045
Q1 2014 $961
Q4 2014 $845
Q3 2013 $656
Q2 2013 $856
Q1 2013 $817
Q4 2013 $865
Q3 2012 $629
Q2 2012 $733
Q1 2012 $701
Q4 2012 $767
Q3 2011 $629
Q2 2011 $614
Q1 2011 $607
Q4 2011 $767
Q3 2010 $421
Q2 2010 $535
Q1 2010 $594
Q4 2010 $697
Q3 2009 $635
Q2 2009 $580
Q1 2009 $570
Q4 2009 $609
Q3 2008 $58
Q2 2008 $493
Q1 2008 $477
Q4 2008 $581
Q3 2007 $375
Q2 2007 $448
Q1 2007 $445
Q4 2007 $455
Q3 2006 $387
Q2 2006 $376
Q1 2006 $341
Q4 2006 $399
Q3 2005 $377
Q2 2005 $287
Q1 2005 $325
Q4 2005 $424
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.680B $214.319B
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $63.438B 21.13
Align Technology (ALGN) United States $24.919B 67.27
AmerisourceBergen (ABC) United States $16.957B 12.04
Laboratory Of America Holdings (LH) United States $16.430B 15.36
Cooper (COO) United States $14.379B 25.08
Cardinal Health (CAH) United States $13.696B 8.87
DENTSPLY SIRONA (XRAY) United States $12.576B 26.22
Henry Schein (HSIC) United States $9.991B 16.80
West Pharmaceutical Services (WST) United States $8.545B 39.69
Merit Medical Systems (MMSI) United States $2.902B 30.14
CONMED (CNMD) United States $2.299B 36.68
Patterson (PDCO) United States $2.100B 16.59
Atrion (ATRI) United States $1.647B 47.04
STAAR Surgical (STAA) United States $1.098B 74.82
Antares Pharma (ATRS) United States $0.476B 0.00
Invacare (IVC) United States $0.225B 0.00
Lifevantage (LFVN) United States $0.160B 21.15
Endologix (ELGX) United States $0.112B 0.00
Pro-Dex (PDEX) United States $0.054B 16.66
Biolase (BIOL) United States $0.042B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.013B 0.00